Chimeric antigen receptor based on BMCA nano-antibody sequence and application thereof

A chimeric antigen receptor and nanobody technology, applied in the field of cellular immunity, can solve the problems of short expression sequence and low tumor killing ability, and achieve the effect of short expression sequence, strong tumor killing ability, and saving space of lentiviral vector

Pending Publication Date: 2019-04-30
深圳市前海精准生物科技有限公司
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Aiming at the deficiencies of the prior art, the present invention provides a chimeric antigen receptor based on the BMCA nanobody sequence and its application, which has a shorter expression sequence and saves limited lentiviral vector space. The chimeric antigen constructed based on the

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Apparently, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

[0023] A chimeric antigen receptor based on the BMCA nanobody sequence, which includes an extracellular domain, a transmembrane domain and a primary signal transduction domain, and the extracellular domain includes an alpaca BCMA polypeptide or a sheep with multiple epitopes Anti-BCMA antibodies or antigen-binding fragments thereof from camels.

[0024] An alpaca BCMA polypeptide or multiple epitope alpaca anti-BCMA antibodies or antigen-binding fragments are obtained by rout...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of cellular immunity, and discloses a chimeric antigen receptor based on a BMCA nano-antibody sequence and an application thereof, wherein the chimeric antigen receptor includes an extracellular structural domain, a transmembrane structural domain and a primary signal transduction domain. The extracellular structural domain includes an alpaca anti-BCMAantibody or an antigen binding fragment of an alpaca BCMA polypeptide or multiple epitopes. The chimeric antigen receptor is mainly applied in tumor treatment drugs, tumors are blood-related tumor diseases, and the blood-related tumor diseases mainly include various types of leukemia and malignant lymphoma. According to the chimeric antigen receptor based on the BMCA nano-antibody sequence and theapplication thereof, the expression sequence is shorter, and the limited space of a lentiviral vector is saved. The chimeric antigen receptor T cell constructed based on the antibody has better specificity and stronger tumor killing ability.

Description

technical field [0001] The invention relates to the technical field of cellular immunity, in particular to a chimeric antigen receptor based on BMCA nanobody sequence and its application. Background technique [0002] In recent years, chimeric antigen receptor (chimeric angiten receptor, CAR) modified T cell-based adoptive immunotherapy of tumors has made great progress. The modified T cells not only have the killing ability to target tumor cells, but also can overcome the local immunosuppressive microenvironment of the tumor and break the state of host immune tolerance. CAR has been developed to the fourth generation through continuous improvement. The first-generation CAR is mainly composed of scFv and ITAM (usually CD3ζ) that recognize tumor-associated antigens, but because only CD3ζ activates the signal, T cells cannot fully proliferate, and the activated T cells survive in vivo for a short time. The second-generation CAR adds a co-stimulatory molecule such as CD28, CD...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K19/00A61K35/17A61P35/00A61P35/02
CPCC07K16/2878A61K35/17A61P35/00A61P35/02C07K14/70517C07K14/70521C07K14/70575C07K14/70578C07K2317/22C07K2319/02C07K2319/03
Inventor 王雨梅志超罗新高
Owner 深圳市前海精准生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap